Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
US Equity | 100.9% |
---|---|
CDN Equity | 0 |
Fixed Income | 0 |
Other | 0 |
Cash | -0.3% |
Int'l Equity | -0.6% |
Healthcare | 100.9% |
---|---|
Basic Mat. | 0 |
Communication Services | 0 |
Consumer Cyclical | 0 |
Consumer Defensive | 0 |
Energy | 0 |
Financial Serv.s | 0 |
Industrials | 0 |
Real Estate | 0 |
Technology | 0 |
Utilities | 0 |
United States | 100.0% |
---|---|
Latin America | 0 |
Africa | 0 |
Asia/Oceania | 0 |
Canada | 0 |
Europe | 0 |
Company Name sortable | Position sortable | Allocation sortable | Allocation sortable1 Month Change | Market Value sortable |
---|---|---|---|---|
Merck & Co Inc | Long | 5.4% | -5.09% | $5.3M |
Amgen Inc | Long | 5.2% | +9.38% | $5.1M |
Becton Dickinson & Co | Long | 5.2% | +8.08% | $5.1M |
Medtronic PLC | Long | 5.2% | +7.20% | $5.1M |
HCA Healthcare Inc | Long | 5.1% | -9.06% | $5.0M |
CVS Health Corp | Long | 5.1% | +4.76% | $5.0M |
The Cigna Group | Long | 5.1% | -10.26% | $5.0M |
Bristol-Myers Squibb Co | Long | 5.1% | +4.87% | $5.0M |
Eli Lilly and Co | Long | 5.1% | -14.80% | $5.0M |
Elevance Health Inc | Long | 5.0% | -0.61% | $4.9M |
Time Horizon | Star Rating |
---|---|
Overall Rating | Not Rated |
3 Year Rating | Not Rated |
5 Year Rating | Not Rated |
10 Year Rating | Not Rated |
Past performance is no guarantee of future results. The ratings reflect historical risk-adjusted performance, and the overall rating is derived from a weight average of the fund's 3, 5, and 10 year (Morningstar Rating) metrics.
Style Box is calculated only using the long position holdings of the portfolio.
Best Fit Index | --- |
---|---|
Category | Sector Equity |
Sponsor | CI Global Asset Management |
Inception | June 7, 2018 |
FHI’s investment objectives are to provide holders, through an actively managed portfolio, with (i) regular cash distributions, (ii) the opportunity for capital appreciation by investing on an equal weight basis in a portfolio of equity securities of at least the 20 largest health care companies measured by market capitalization listed on a North American stock exchange, and (iii) lower overall volatility of returns on the portfolio than would be experienced by owning a portfolio of securities of such issuers directly, by employing a covered call option writing program. The issuers included in the portfolio, which are based on their market capitalization, may be adjusted based on the Portfolio Manager’s view on the liquidity of the issuers’ equity securities and their related call options.
Total Net Assets | $19.1M |
---|---|
Shares Out. | 1.4M |
Net Asset Value (NAV) | $12.53 |
Prem/Discount to NAV | 1.26% |
P/E Ratio | 26.5 |
Dividend Yield | 6.42% |
Dividend per Share | 0.80 CAD |
Ex-Dividend Date | 03/21/2024 |
Dividend Payment Date | 03/28/2024 |
Beta | --- |
Morningstar Investment Style | Sector Equity |
Equity Style | Large Cap Value |
Credit Quality / Duration | --- |
Actual Management Fee | 0.65% |
---|---|
Actual Mgmt. Expense Ratio (MER) | 0.73% |